InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Ross Jeffrey James, Chief Executive Officer. Insider active across 1 company, notably Miromatrix Medical Inc.. Aggregated, 11 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €47k. Activity tracked since 13 January 2022. The latest transaction was disclosed on 10 March 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations11 total
308,775 sharesCommon StockSEC:0001415889-23-016371:0
31,250 shares@ US$1.6035.7% of flowCommon StockSEC:0001415889-23-005636:0
Ideal exit: 5 Dec 2023 (T+270)
50,000 shares0Common StockSEC:0001415889-23-001095:0
37,500 shares@ US$1.2533.7% of flowCommon StockSEC:0001415889-22-012270:0
35,438 shares@ US$1.25100.0% of flowCommon StockSEC:0001415889-22-003137:0
4,400 shares0Common StockSEC:0001415889-22-000633:0
50,000 shares0Common StockSEC:0001415889-22-000634
4,400 shares0Common StockSEC:0001415889-22-000633
50,000 shares0Common StockSEC:0001415889-22-000634:0
4,400 sharesCommon StockSEC:0001179110-21-007128
4,400 sharesCommon StockSEC:0001179110-21-007128:0
11 of 11 declarations
About Ross Jeffrey James
Jeffrey James Ross is the Chief Executive Officer at Miromatrix Medical Inc. In this role, he leads the company's operations and strategy, focusing on the development of innovative medical solutions. With significant experience in the medical sector, Jeffrey is responsible for overseeing research and development initiatives and commercial growth at Miromatrix. His leadership is essential to position the company as a key player in the field of regenerative medicine.
